Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Study Evaluating the Interest of PET to 18F-Fludarabine for the Initial Assessment and End-treatment Evaluation of Patients With Symptomatic Multiple Myeloma in the First Line of Treatment, Not Candidates for Marrow Autograft

NCT03832127 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT03832127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03832127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Study Evaluating the Interest of PET to 18F-Fludarabine for the Initial Assessment and End-treatment Evaluation of Patients With Symptomatic Multiple Myeloma in the First Line of Treatment, Not Candidates for Marrow Autograft
Lead sponsor
Nantes University Hospital
Phase
Phase 1
Overall status
Recruiting
Start date
September 9, 2022
Completion date
September 9, 2026
Enrollment
35 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

myeloma